Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Exploring the Genomes of Cancer Cells: Progress and Promise
Michael R. Stratton*
Abstract:
The description and interpretation of genomic abnormalities in cancer cells have been at the heart of cancer research for more than a century. With exhaustive sequencing of cancer genomes across a wide range of human tumors well under way, we are now entering the end game of this mission. In the forthcoming decade, essentially complete catalogs of somatic mutations will be generated for tens of thousands of human cancers. Here, I provide an overview of what these efforts have revealed to date about the origin and behavioral features of cancer cells and how this genomic information is being exploited to improve diagnosis and therapy of the disease.
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
* E-mail: mrs{at}sanger.ac.uk
The editors suggest the following Related Resources on Science sites:
In Science Magazine
INTRODUCTION TO SPECIAL ISSUE
Paula Kiberstis and Eliot Marshall (25 March 2011) Science331 (6024), 1539-a.
[DOI: 10.1126/science.331.6024.1539-a] |Full Text »|PDF »
In Science Signaling
EDITORIAL GUIDES
Elizabeth M. Adler and Nancy R. Gough (29 March 2011) Sci. Signal.4 (166), eg3.
[DOI: 10.1126/scisignal.2002014] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing.
E. Heitzer, M. Auer, C. Gasch, M. Pichler, P. Ulz, E. M. Hoffmann, S. Lax, J. Waldispuehl-Geigl, O. Mauermann, C. Lackner, et al. (2013)
Cancer Res.
73, 2965-2975
|Abstract »|Full Text »|PDF »
Breakpoint profiling of 64 cancer genomes reveals numerous complex rearrangements spawned by homology-independent mechanisms.
A. Malhotra, M. Lindberg, G. G. Faust, M. L. Leibowitz, R. A. Clark, R. M. Layer, A. R. Quinlan, and I. M. Hall (2013)
Genome Res.
23, 762-776
|Abstract »|Full Text »|PDF »
Single-cell paired-end genome sequencing reveals structural variation per cell cycle.
T. Voet, P. Kumar, P. Van Loo, S. L. Cooke, J. Marshall, M.-L. Lin, M. Zamani Esteki, N. Van der Aa, L. Mateiu, D. J. McBride, et al. (2013)
Nucleic Acids Res.
|Abstract »|Full Text »|PDF »
Laser capture microdissection-reduced representation bisulfite sequencing (LCM-RRBS) maps changes in DNA methylation associated with gonadectomy-induced adrenocortical neoplasia in the mouse.
M. Schillebeeckx, A. Schrade, A.-K. Lobs, M. Pihlajoki, D. B. Wilson, and R. D. Mitra (2013)
Nucleic Acids Res.
|Abstract »|Full Text »|PDF »
The Scientific Drunk and the Lamppost: Massive Sequencing Efforts in Cancer Discovery and Treatment.
Whole-Exome Sequencing Studies of Nonfunctioning Pituitary Adenomas.
P. J. Newey, M. A. Nesbit, A. J. Rimmer, R. A. Head, C. M. Gorvin, M. Attar, L. Gregory, J. A. H. Wass, D. Buck, N. Karavitaki, et al. (2013)
J. Clin. Endocrinol. Metab.
98, E796-E800
|Abstract »|Full Text »|PDF »
CUL3 and NRF2 Mutations Confer an NRF2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma.
A. Ooi, K. Dykema, A. Ansari, D. Petillo, J. Snider, R. Kahnoski, J. Anema, D. Craig, J. Carpten, B.-T. Teh, et al. (2013)
Cancer Res.
73, 2044-2051
|Abstract »|Full Text »|PDF »
Diagnostic Cancer Genome Sequencing and the Contribution of Germline Variants.
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.
W. Yang, J. Soares, P. Greninger, E. J. Edelman, H. Lightfoot, S. Forbes, N. Bindal, D. Beare, J. A. Smith, I. R. Thompson, et al. (2013)
Nucleic Acids Res.
41, D955-D961
|Abstract »|Full Text »|PDF »
Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling.
Y.-P. Liu, C.-J. Yang, M.-S. Huang, C.-T. Yeh, A. T. H. Wu, Y.-C. Lee, T.-C. Lai, C.-H. Lee, Y.-W. Hsiao, J. Lu, et al. (2013)
Cancer Res.
73, 406-416
|Abstract »|Full Text »|PDF »
Copy-number-aware differential analysis of quantitative DNA sequencing data.
M. D. Robinson, D. Strbenac, C. Stirzaker, A. L. Statham, J. Song, T. P. Speed, and S. J. Clark (2012)
Genome Res.
22, 2489-2496
|Abstract »|Full Text »|PDF »
Analysis of mRNA Profiles after MEK1/2 Inhibition in Human Pancreatic Cancer Cell Lines Reveals Pathways Involved in Drug Sensitivity.
S. Gysin, J. Paquette, and M. McMahon (2012)
Mol. Cancer Res.
10, 1607-1619
|Abstract »|Full Text »|PDF »
Comparative analysis of somatic copy-number alterations across different human cancer types reveals two distinct classes of breakpoint hotspots.
Y. Li, L. Zhang, R. L. Ball, X. Liang, J. Li, Z. Lin, and H. Liang (2012)
Hum. Mol. Genet.
21, 4957-4965
|Abstract »|Full Text »|PDF »
Loss of SNAIL Regulated miR-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells.
P. Qian, A. Banerjee, Z.-S. Wu, X. Zhang, H. Wang, V. Pandey, W.-J. Zhang, X.-F. Lv, S. Tan, P. E. Lobie, et al. (2012)
Cancer Res.
72, 6036-6050
|Abstract »|Full Text »|PDF »
Whole-Exome Sequencing Studies of Nonhereditary (Sporadic) Parathyroid Adenomas.
P. J. Newey, M. A. Nesbit, A. J. Rimmer, M. Attar, R. T. Head, P. T. Christie, C. M. Gorvin, M. Stechman, L. Gregory, R. Mihai, et al. (2012)
J. Clin. Endocrinol. Metab.
97, E1995-E2005
|Abstract »|Full Text »|PDF »
The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine.
Oncogenic cooperation between SOCS family proteins and EGFR identified using a Drosophila epithelial transformation model.
H. Herranz, X. Hong, N. T. Hung, P. M. Voorhoeve, and S. M. Cohen (2012)
Genes & Dev.
26, 1602-1611
|Abstract »|Full Text »|PDF »
DNA Methylation As a Clinical Marker in Oncology.
J.-P. Issa (2012)
J. Clin. Oncol.
30, 2566-2568
|Full Text »|PDF »
Attacking a Nexus of the Oncogenic Circuitry by Reversing Aberrant eIF4F-Mediated Translation.
P. B. Bitterman and V. A. Polunovsky (2012)
Mol. Cancer Ther.
11, 1051-1061
|Abstract »|Full Text »|PDF »
Predictive Biomarkers in Advance of a Companion Drug: Ahead of Their Time?.
R. K. Kelley, C. Atreya, A. P. Venook, and P. G. Febbo (2012)
J Natl Compr Canc Netw
10, 303-309
|Abstract »|Full Text »|PDF »
Order-of-magnitude Estimates of Latency (Time to Appearance) and Refill Time of a Cancer from a Single Cancer 'Stem' Cell Compared by an Exponential and a Logistic Equation.
K. M. ANDERSON, M. RUBENSTEIN, P. GUINAN, and M. PATEL (2012)
In Vivo
26, 183-189
|Abstract »|Full Text »|PDF »
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing.
D. C. Koboldt, Q. Zhang, D. E. Larson, D. Shen, M. D. McLellan, L. Lin, C. A. Miller, E. R. Mardis, L. Ding, and R. K. Wilson (2012)
Genome Res.
22, 568-576
|Abstract »|Full Text »|PDF »
Detecting genomic indel variants with exact breakpoints in single- and paired-end sequencing data using SplazerS.
A.-K. Emde, M. H. Schulz, D. Weese, R. Sun, M. Vingron, V. M. Kalscheuer, S. A. Haas, and K. Reinert (2012)
Bioinformatics
28, 619-627
|Abstract »|Full Text »|PDF »
Exploiting the Mutanome for Tumor Vaccination.
J. C. Castle, S. Kreiter, J. Diekmann, M. Lower, N. van de Roemer, J. de Graaf, A. Selmi, M. Diken, S. Boegel, C. Paret, et al. (2012)
Cancer Res.
72, 1081-1091
|Abstract »|Full Text »|PDF »
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.
J. Wu, Y. Jiao, M. Dal Molin, A. Maitra, R. F. de Wilde, L. D. Wood, J. R. Eshleman, M. G. Goggins, C. L. Wolfgang, M. I. Canto, et al. (2011)
PNAS
108, 21188-21193
|Abstract »|Full Text »|PDF »
Correct End Use during End Joining of Multiple Chromosomal Double Strand Breaks Is Influenced by Repair Protein RAD50, DNA-dependent Protein Kinase DNA-PKcs, and Transcription Context.
A. Gunn, N. Bennardo, A. Cheng, and J. M. Stark (2011)
J. Biol. Chem.
286, 42470-42482
|Abstract »|Full Text »|PDF »